Society Pass shares are trading lower after partnering with Trip Ninja to expand operations, raising investor concerns about the collaboration's success in driving growth and reducing operational risks.

AGL shares are trading lower after the announcement of an investigation into the company for potential securities fraud violations and the stepping down of its President, CEO, and Board Director Steven Sell, along with the withdrawal of its 2025 earnings guidance.

Proficient Auto Logistics shares are trading lower after the company reported a significant operating loss for the full year 2025, primarily driven by a $27.8 million non-cash goodwill impairment charge, and a decrease in adjusted operating income year-over-year.

LuxExperience shares are trading higher after the company reported positive Q2 FY26 financial results, demonstrating significant growth and a return to adjusted EBITDA profitability. The company's successful execution of its transformation plan and strategic focus on cost discipline contributed to the improvement across all segments, including Mytheresa, NET-A-PORTER, and MR PORTER.

Vestis Corporation shares are trading higher after the company reported improved Adjusted EBITDA and cash flow figures, highlighting the success of its strategic business transformation plan despite a net loss for the quarter.

Sutro Biopharma shares are trading higher after the company announced a successful $110 million underwritten stock offering.

Harvard Bioscience shares are trading higher after the company reported preliminary fourth quarter financial results in line with guidance and a positive outlook for 2026.

Hoth Therapeutics shares are trading higher after the company announced that their HT-VA GDNF treatment surpassed semaglutide in weight loss, glucose control, and liver health in a preclinical obesity model.

European Wax Center shares are trading higher after the company entered an agreement to be taken private by General Atlantic in an all-cash deal, offering $5.80 per share, representing a 45% premium to the previous closing price.

S&P Global shares are trading lower after the company reported its fourth-quarter and full-year 2025 results, which failed to meet investor expectations.

Personalis shares are trading higher after the company announced Medicare coverage for its NeXT Personal molecular residual disease test, expanding access for lung cancer surveillance.

Nektar Therapeutics shares are trading higher after the company announced positive results from its 36-week Phase 2b REZOLVE-AD study, showcasing the potential of its promising drug rezpegaldesleukin for treating atopic dermatitis.

Harley-Davidson shares are trading lower after the company reported a significant decline in quarterly and full-year financial results, with revenue dropping 28% in Q4 and 14% for the year, alongside a 16% decrease in global motorcycle shipments.

Datadog shares are trading higher after the company announced a 29% year-over-year increase in fourth-quarter revenue, reaching $953 million, driven by strong growth in larger customers and the launch of new AI-powered features.

Clear Channel Outdoor Holdings shares are trading higher after the company agreed to be acquired by Mubadala Capital and TWG Global for $6.2 billion, representing a 71% premium to its unaffected share price.

BDX shares are trading lower after the company reported its first-quarter fiscal 2026 results and completed the spin-off of its Biosciences & Diagnostic Solutions business, combining it with Waters Corporation.

Energy Services of America shares are trading higher after the company reported a 13.4% year-over-year revenue increase and a substantial rise in net income for the first quarter of fiscal 2026.

The Goodyear Tire & Rubber Company shares are trading lower after reporting mixed 2025 financial results, including a significant net loss and lower segment operating income amid challenging industry conditions.

ZoomInfo (NASDAQ: GTM) shares are trading lower after the company reported modest revenue growth of 3% year-over-year, coupled with high operating expenses and share repurchase activities impacting investor confidence.

REGENXBIO shares are trading lower after the FDA issued a Complete Response Letter for its RGX-121 BLA application, citing several reasons for non-approval, including study eligibility criteria and data evaluation challenges.